News

Duluth Holdings Inc. Sets the Stage for Q4 Fiscal Insights

Duluth Holdings Inc. Sets the Stage for Q4 Fiscal Insights

Upcoming Financial Results for Duluth Holdings Inc.

Duluth Holdings Inc. (dba, Duluth Trading Company) (NASDAQ: DLTH), recognized as a prominent lifestyle brand for casual and workwear, has announced a date to share its fourth quarter 2024 financial results. Set to be disclosed on a Thursday morning, March 13, 2025, prior to market opening, this announcement is highly anticipated by analysts and investors alike.

Details of the Conference Call

On the same day, March 13, at 9:30 am Eastern Time, Duluth Trading will host a conference call. This is an excellent opportunity for analysts and investors to hear directly from the company regarding its latest performance and future trajectory. Attendees can join the call by dialing in: 1-844-875-6915 for domestic calls or 1-412-317-6711 for international participants.

Don’t worry if you miss the live event; a replay will be available until March 20, 2025. The domestic replay number is 1-877-344-7529, and for international inquiries, the replay can be accessed at 1-412-317-0088. The replay access code to use is 6076354 to ensure quick access to the information you need.

About Duluth Trading Company

Duluth Trading Company is renowned for designing innovative solutions that cater to the needs of the Modern, Self-Reliant American. With headquarters in Wisconsin, this brand excels in providing high-quality casual wear, workwear, and accessories specifically crafted for individuals who embrace an active lifestyle and take pride in their work ethic.

Engaging Customer Experiences

What sets Duluth apart is not just its product range but the engaging experience it offers customers. The company employs an entertaining marketing approach that blends humor and storytelling, showcasing the uniqueness of its offerings in a fun manner. Additionally, all products are strategically marketed through various channels, such as a content-rich website, catalogs, and engaging retail locations that promise a shopping experience like no other.

Duluth Trading stands firm on its commitment to customer satisfaction, backed by the promise of its "No Bull Guarantee". This pledge means that if customers are not completely satisfied, the company will resolve any issues, ensuring an unwavering focus on quality and service.

Investor Engagement and Contact Information

Investor relations are an integral part of Duluth Holdings Inc.'s strategy. The company encourages any investor inquiries to be directed to Tom Filandro at ICR, Inc., reachable by phone at 646-277-1200 or through email at DuluthIR@icrinc.com. Staying connected with both investors and customers is a priority that enhances trust and transparency within the community.

Future Growth Prospects

As Duluth Holdings Inc. positions itself for future growth, the upcoming financial report is essential for investors looking to gauge the financial health and market dynamics of the company. The continued evolution of the retail landscape creates both challenges and opportunities for brands like Duluth, making this report highly relevant.

Frequently Asked Questions

When will Duluth Holdings report its financial results?

Duluth Holdings Inc. will report its fourth quarter 2024 financial results on March 13, 2025.

What is the conference call number for investors?

Investors can join the conference call by dialing 1-844-875-6915 for domestic calls and 1-412-317-6711 for international calls.

How can I access the conference call replay?

The conference call replay will be available until March 20, 2025, using the numbers 1-877-344-7529 for domestic and 1-412-317-0088 for international calls, with access code 6076354.

What is the "No Bull Guarantee"?

Duluth Trading's "No Bull Guarantee" means that if customers are not satisfied with a product, the company will resolve the issue, ensuring complete customer satisfaction.

Who can I contact for investor relations?

Investors can reach out to Tom Filandro at ICR, Inc. by calling 646-277-1200 or emailing DuluthIR@icrinc.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading